Loading stock data…
CLNN
$6.14-0.02 (-0.32%)
Market ClosedLast close May 1
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Clene Inc. in the Consumer Defensive sector is trading at $6.14. The stock is currently 55% below its 52-week high of $13.50, remaining 1.0% below its 200-day moving average. Technical signals show neutral RSI of 43 and bearish MACD signal, explaining why CLNN maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 43) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.14
Potential Upside
5%
Whystock Fair Value$6.45
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Mean target$30.33+394.0%
Range$20.00 – $48.00
Fundamentals
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in vario...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$77.38M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.62
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
138.93%
Volume
Today's trading volume
61,681
Recent News
3 Growth Stocks With High Insider Ownership Achieving 19% Revenue Growth
Over the last 7 days, the United States market has remained flat, yet it is up 29% over the past year with earnings forecast to grow by 16% annually. In this environment, identifying growth stocks with high insider ownership can be appealing as these companies often benefit from strong alignment between management and shareholders, potentially driving sustainable revenue growth.
3 Growth Companies With High Insider Ownership Expecting 28% Revenue Growth
The United States market remained flat over the last week, yet it has experienced a remarkable 29% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may be well-positioned to capitalize on expected revenue growth.
3 Growth Companies With High Insider Ownership And 25% Revenue Growth
The United States market remained flat over the last week, yet it has experienced a robust 28% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership and significant revenue growth can be particularly appealing as they may suggest strong confidence from those closest to the business.
Top Growth Stocks With Notable Insider Ownership
Over the last 7 days, the United States market has remained flat, but it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.
Insider Owned Growth Companies To Watch In April 2026
The United States market has remained flat over the last week but has experienced a significant 29% increase over the past year, with earnings forecasted to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they may indicate strong confidence in the company's future prospects from those who know it best.